Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Med (New York, N.Y.)|November 22, 2025
The comings and goings of cell-free DNA: Biological and clinical implicationsYasine Malki, Qing Zhou, Peiyong Jiang, et al.
Nature Reviews. Clinical Oncology|October 8, 2025
Achieving control of nasopharyngeal carcinoma: the role of Epstein-Barr virus-based screening and vaccinesW K Jacky Lam, Brigette B Y Ma, Ann D King, et al.
International Journal of Molecular Sciences|February 26, 2025
Cell-Free Nucleic Acids for Early Diagnosis of Acute Ischemic Stroke: A Systematic Review and Meta-AnalysisXiaodan Zhang, Yuee Cai, Brian Hon Man Sit, et al.
Translational Neurodegeneration|February 14, 2022
LRRK2 mutant knock-in mouse models: therapeutic relevance in Parkinson's diseaseEunice Eun Seo Chang, Philip Wing-Lok Ho, Hui-Fang Liu, et al.
International Journal of Molecular Sciences|April 12, 2022
Transcriptional Regulation of the Synaptic Vesicle Protein Synaptogyrin-3 (SYNGR3) Gene: The Effects of NURR1 on Its ExpressionLingfei Li, Philip Wing-Lok Ho, Huifang Liu, et al.
Cell Communication and Signaling : CCS|October 10, 2024
Loss of mitochondrial Ca2+ response and CaMKII/ERK activation by LRRK2R1441G mutation correlate with impaired depolarization-induced mitophagyEunice Eun-Seo Chang, Huifang Liu, Zoe Yuen-Kiu Choi, et al.
Brain and Behavior|January 10, 2023
In vivo overexpression of synaptogyrin-3 promotes striatal synaptic dopamine uptake in LRRK2R1441G mutant mouse model of Parkinson's diseasePhilip Wing-Lok Ho, Lingfei Li, Hui-Fang Liu, et al.
Translational Neurodegeneration|February 1, 2022
LRRK2, GBA and their interaction in the regulation of autophagy: implications on therapeutics in Parkinson's diseaseShirley Yin-Yu Pang, Rachel Cheuk Nam Lo, Philip Wing-Lok Ho, et al.
NPJ Parkinson'S Disease|December 12, 2025
Long-term oral glucocerebrosidase activator reduces soluble α-synuclein oligomer accumulation in Parkinsonian LRRK2 mutant mouse brainZoe Yuen-Kiu Choi, Huifang Liu, Eunice Eun-Seo Chang, et al.
NPJ Parkinson'S Disease|September 10, 2022
Long-term inhibition of mutant LRRK2 hyper-kinase activity reduced mouse brain α-synuclein oligomers without adverse effectsPhilip Wing-Lok Ho, Eunice Eun-Seo Chang, Chi-Ting Leung, et al.
Pageof 2